Switch to:

Orgenesis Shiller PE Ratio

: (As of Today)
View and export this data going back to 2010. Start your Free Trial

Shiller PE for Stocks: The True Measure of Stock Valuation

Orgenesis Shiller PE Ratio Historical Data

The historical data trend for Orgenesis's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orgenesis Annual Data
Trend Nov12 Nov13 Nov14 Nov15 Nov16 Nov17 Nov18 Dec19 Dec20 Dec21
Shiller PE Ratio
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Orgenesis Quarterly Data
May17 Aug17 Nov17 Feb18 May18 Aug18 Nov18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22
Shiller PE Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison

For the Biotechnology subindustry, Orgenesis's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orgenesis Shiller PE Ratio Distribution

For the Biotechnology industry and Healthcare sector, Orgenesis's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Orgenesis's Shiller PE Ratio falls into.

Orgenesis Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Orgenesis's E10 for the quarter that ended in Mar. 2022 is calculated as:

For example, Orgenesis's adjusted earnings per share data for the three months ended in Mar. 2022 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Mar. 2022 (Change)*Current CPI (Mar. 2022)

Current CPI (Mar. 2022) = 121.3010.

Orgenesis Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201205 -0.240 96.961 -0.300
201208 -0.480 97.199 -0.599
201211 -0.360 97.133 -0.450
201302 -0.360 97.953 -0.446
201305 -0.360 98.282 -0.444
201308 -0.240 98.675 -0.295
201311 -0.360 98.334 -0.444
201402 -0.120 99.057 -0.147
201405 -0.360 100.373 -0.435
201408 -0.720 100.352 -0.870
201411 0.000 99.635 0.000
201502 -0.240 99.032 -0.294
201505 -0.360 100.333 -0.435
201508 -0.480 100.548 -0.579
201511 -0.240 100.135 -0.291
201602 0.012 100.040 0.015
201605 -0.480 101.355 -0.574
201608 -0.240 101.617 -0.286
201611 -0.580 101.829 -0.691
201702 -0.660 102.779 -0.779
201705 -0.260 103.256 -0.305
201708 -0.400 103.587 -0.468
201711 0.030 104.072 0.035
201802 -0.520 105.052 -0.600
201805 -0.200 106.148 -0.229
201808 -0.350 106.383 -0.399
201811 -0.390 106.338 -0.445
201903 -0.550 107.251 -0.622
201906 -0.360 108.070 -0.404
201909 -0.440 108.329 -0.493
201912 -0.420 108.420 -0.470
202003 4.230 108.902 4.712
202006 -0.950 108.767 -1.059
202009 -0.110 109.815 -0.122
202012 -2.270 109.897 -2.506
202103 -0.010 111.754 -0.011
202106 -0.110 114.631 -0.116
202109 -0.420 115.734 -0.440
202112 -0.200 117.630 -0.206
202203 -0.160 121.301 -0.160

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Orgenesis  (NAS:ORGS) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.

Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.

Orgenesis Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of Orgenesis's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Orgenesis Business Description

Orgenesis logo
Healthcare » Biotechnology NAICS : 325412 SIC : 2834
Traded in Other Exchanges
20271 Goldenrod Lane, Germantown, MD, USA, 20876
Orgenesis Inc is a part of the healthcare sector. It is a fully-integrated biopharmaceutical company focused on developing trans-differentiation technologies for diabetes and vertically integrating manufacturing that can optimize its abilities to scale-up its technologies for clinical trials and eventual commercialization. The group operates in two segments namely CDMO and POC. The company is also engaged in applying its disciplined execution to emerging technologies of other cell therapy markets in such areas as cell-based cancer immunotherapies and neurodegenerative diseases.
Reithinger Neil officer: CFO, Treasurer and Secretary 14950 N. 83RD PLACE SUITE 1 SCOTTSDALE AZ 85260
Philips Mario director C/O ATMI, INC DANBURY CT 06810
Ferber Sarah officer: Chief Scientific Officer 17B HAHASKALA STREET TEL AVIV L3 67890
Yachin Guy director 7 ORCHARD WAY N POTOMAC MD 20854
Nanda Ashish director 2301, 23RD FLOOR, TIFFANY TOWERS CLUSTER W, JLT, DUBAI, UAE DUBAI C0 4452
Bedoret Denis officer: See Remarks 48, RUE AUGUSTE PICCARD GOSSELIES C9 6041
Universite Libre De Bruxelles other: less than 10% AVENUE F, ROOSEVELT, 50 BRUSSELS C9 1050
Theodorus Ii Sa other: less than 10% ALLEE DE LA RECHERCHE, 12 BRUSSELS C9 1070
Theodorus Sca other: less than 10% ALLEE DE LA RECHERCHE, 12 BRUSSELS C9 1070
Belenger Olivier other: less than 10% DIEWEG, 69 BRUSSELS C9 1070
Shvartz Oded 10 percent owner 130 BIRUINTEI BVD. PANTELIMON, ILFOV S5 0000000
Bultot Hugues director AVENUE DE L??HORIZON 24 WOLUWE SAINT PIERRE C9 1150
Buyse Chris Georges Frans director BAILLET LATOURLEI 119A BRUSSELS C9 2390
Tenne Joseph officer: CFO Treasurer Secretary 6225 NEIL ROAD, SUITE 300 C/O ORMAT TECHNOLOGIES, INC. RENO NV 89511

Orgenesis Headlines

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)